15 / 280
IV.
Rhinology
Boghani Z, Husain Q, Kanumuri VV, et al. Juvenile nasopharyngeal angiofibroma: a
systematic review and comparison of endoscopic, endoscopic-assisted, and open
resection in 1047 cases.
Laryngoscope
. 2013; 123(4):859-869. EBM
level 3a......................................................................................................................111-121
Summary: This article presents a systematic review of English-language articles
reporting on results of surgical management of juvenile nasopharyngeal
angiofibroma published between 1990 and 2012. The authors separately analyze
those studies reporting individual patient data (mainly case reports and small case
series) and aggregate patient data (larger case series and prospective studies).
Brietzke, SE, Shin JJ, Choi S, et al. Clinical consensus statement: pediatric chronic
rhinosinusitis.
Otolaryngol Head Neck Surg
. 2014; 151(4):542-553. EBM
level 5.......................................................................................................................122-133
Summary: This article is a summary of an expert panel consensus which was
convened to help optimize the diagnosis and management of pediatric chronic
rhinosinusitis (PCRS). The conclusions were assembled after using a Delphi
method survey of nine experts and can be categorized as topics relevant to the
definition and diagnosis of PCRS, medical management, adenoiditis/adenoidectomy,
and endoscopic sinus surgery and turbinate surgery.
Lindstrand A, Bennet R, Galanis I, et al. Sinusitis and pneumonia hospitalization after
introduction of pneumococcal conjugate vaccine.
Pediatrics
. 2014; 134(6):e1528-e1536.
EBM level 3..............................................................................................................134-142
Summary: This is a population study examining the risk of hospitalization for
pneumonia, sinusitis, and empyema following vaccination with pneumococcal
conjugate vaccines PCV7 and PCV13. This study shows reduced risk of
hospitalization for pneumonia in children under age 5 years and sinusitis in children
under 2 years.
Olarte L, Hulten KG, Lamberth L, et al. Impact of the 13-valent pneumococcal conjugate
vaccine on chronic sinusitis associated
Streptococcus pneumoniae
in children.
Pediatr
Infect Dis J
. 2014; 33(10):1033-1036. EBM level 3..............................................143-146
Summary: This is a retrospective study of 91 pediatric patients who underwent
endoscopic sinus surgery and
S. pneumoniae
was identified via intraoperative
culture. Comparison was made of the serotype of
S. pneumoniae
identified before
and after 13-valent pneumococcal conjugate vaccine (PCV13) vaccinations were
implemented. Following the introduction of PCV13, the rate of isolation of
S.
pneumoniae
decreased, particularly of serotype 19A.